Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tivozanib: status of development.
Jamil MO, Hathaway A, Mehta A. Jamil MO, et al. Among authors: mehta a. Curr Oncol Rep. 2015 Jun;17(6):24. doi: 10.1007/s11912-015-0451-3. Curr Oncol Rep. 2015. PMID: 25895472 Review.
Novel agents for the treatment of Hodgkin lymphoma.
Dumaswala K, Mehta A. Dumaswala K, et al. Among authors: mehta a. Expert Rev Hematol. 2015 Oct;8(5):659-67. doi: 10.1586/17474086.2015.1081562. Expert Rev Hematol. 2015. PMID: 26343891 Review.
Treatment approaches of hard-to-treat non-Hodgkin lymphomas.
Nandagopal L, Mehta A. Nandagopal L, et al. Among authors: mehta a. Expert Rev Hematol. 2017 Mar;10(3):259-273. doi: 10.1080/17474086.2017.1283214. Epub 2017 Feb 15. Expert Rev Hematol. 2017. PMID: 28094575 Review.
Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b-2 study.
Tilly H, Morschhauser F, Bartlett NL, Mehta A, Salles G, Haioun C, Munoz J, Chen AI, Kolibaba K, Lu D, Yan M, Penuel E, Hirata J, Lee C, Sharman JP. Tilly H, et al. Among authors: mehta a. Lancet Oncol. 2019 Jul;20(7):998-1010. doi: 10.1016/S1470-2045(19)30091-9. Epub 2019 May 14. Lancet Oncol. 2019. PMID: 31101489 Clinical Trial.
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
Bartlett NL, Herrera AF, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R, Armand P, Devata S, Izquierdo AR, Lossos IS, Reeder C, Sher T, Chen R, Schwarz SE, Alland L, Strassz A, Prier K, Choe-Juliak C, Ansell SM. Bartlett NL, et al. Among authors: mehta a. Blood. 2020 Nov 19;136(21):2401-2409. doi: 10.1182/blood.2019004701. Blood. 2020. PMID: 32730586 Free PMC article. Clinical Trial.
5,663 results